Search - tctmd.com

Displaying 221 - 240 of 252

Sort: Relevancy | Date

News Daily News

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Shelley Wood

May 02, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2017

Shelley Wood

March 01, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Daily News

After a Lull, Cardioband Purchase Represents Latest in Mitral Valve Tech Acquisitions

Shelley Wood

November 30, 2016

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

Shelley Wood

November 16, 2016

Presentation AHA 2016

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

Presenter: David M Kaye

November 15, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

Presentation TCT 2016

Role of Surgical and Transcatheter Tricuspid Valve Repair for Patients With Heart Failure

Presenter: Jeroen J. Bax, Ileana L. Pina, Joachim Schofer

October 31, 2016

Presentation TCT 2016

Surgical and Transcatheter Mitral Valve Repair or Replacement for Patients With Heart Failure and Primary and Secondary MR: Magnitude of Benefit and Prediction of Responders

Presenter: Jeroen J. Bax, Ileana L. Pina, Marco Moscarelli

October 31, 2016

Presentation TCT 2016

Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and High and Low Gradient Aortic Stenosis: Magnitude of Benefit and Prediction of Responders

Presenter: Jeroen J. Bax, Ileana L. Pina, Ori Ben-Yehuda

October 31, 2016

News Industry News

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

June 27, 2016

Presentation TVT 2016

TVT 1130: Transcatheter Aortic Valve Implantation in a Heart-Failure Patient With a Left Ventricular Assist Device and Severe Aortic Regurgitation

Presenter: Frank van der kley, MD

June 17, 2016

News Industry News

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

May 12, 2016

Presentation

Transcatheter Intracardiac Shunt Device for Heart Failure With Preserved Ejection Fraction

Presenter: Gerd Hasenfuss

March 29, 2016

News Daily News

Percutaneous Interatrial Shunts May Offer New Hope for Advanced Heart Failure Patients

L.A. McKeown

March 29, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Industry News

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

December 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

Advertisement

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

TCTMD’s Top 10 Most Popular Stories for February 2017

TCTMD’s Top 10 Most Popular News and Features for 2016

After a Lull, Cardioband Purchase Represents Latest in Mitral Valve Tech Acquisitions

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Role of Surgical and Transcatheter Tricuspid Valve Repair for Patients With Heart Failure

Surgical and Transcatheter Mitral Valve Repair or Replacement for Patients With Heart Failure and Primary and Secondary MR: Magnitude of Benefit and Prediction of Responders

Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and High and Low Gradient Aortic Stenosis: Magnitude of Benefit and Prediction of Responders

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

TVT 1130: Transcatheter Aortic Valve Implantation in a Heart-Failure Patient With a Left Ventricular Assist Device and Severe Aortic Regurgitation

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

Transcatheter Intracardiac Shunt Device for Heart Failure With Preserved Ejection Fraction

Percutaneous Interatrial Shunts May Offer New Hope for Advanced Heart Failure Patients

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content